Clin2
NCT06999499Possibly a fitNot yet recruiting

AI tool to help detect melanoma from mole photos

Naevi

Part of Cancer clinical trials.

This study is testing a computer program that uses photos of your moles to help doctors find skin cancer (melanoma) earlier. If you have many moles, joining could help improve this technology for everyone.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have more than 15 moles (nevi)
  • Your skin type is light to medium (phototypes I to III)
  • You do not have chronic inflammatory skin diseases
  • You are not claustrophobic (the imaging system may feel enclosed)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06788665Not yet recruiting
Testing a device that measures melanoma depth from photos

This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.

Gothenburg
NCT07740642Not yet recruiting
Comparing two whole-body imaging systems for skin cancer screening

This study compares two different whole-body imaging systems that take pictures of your skin to screen for skin cancer. It looks at which system is easier and more comfortable for people at higher risk of melanoma.

Basel, Canton of Basel-City
NCT05446155Recruiting
Studying test results to predict and diagnose melanoma

This study looks at diagnostic and prognostic factors in people who have suspicious pigmented skin lesions or melanoma that doctors are evaluating with surgery or tissue sampling. It may help improve how clinicians decide what the lesion is and what to expect over time.

Helsingborg, Skåne County
NCT06932172Recruiting
AI tool to help diagnose skin cancer in primary care

This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.

Finspång, Docent
NCT06064019Recruiting
Using Nevisense to help diagnose skin cancer

This study tests a device called Nevisense that helps doctors check if a suspicious skin spot is a type of skin cancer called keratinocyte cancer (including basal cell carcinoma, squamous cell carcinoma, and related conditions like actinic keratosis). If you have a spot that your doctor is unsure about, this tool may help get a clearer answer.

Wuppertal
NCT07144306Recruiting
AI-powered skin cancer detection study

This trial tests an artificial intelligence system designed to spot skin cancer early. You may be able to join if you are an adult with a suspicious skin spot and can give permission to participate.

London

Hear when a new Naevi trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.